Novelty enhancement

Novelty enhancement is a shift in cognitive appraisal in which familiar things feel newly interesting, strange, or significant — as though encountered for the first time.

As a drug effect it is acute and dose-proportional, fading as the substance wears off. It ranges from a mild brightening of interest toward everyday objects and ideas to an intense sense that the world is inexhaustibly rich and has never quite been seen before.

Novelty enhancement is among the more commonly reported desirable cognitive effects across psychoactive substances. It is most commonly induced at moderate to high doses under psychedelics such as LSD, psilocybin mushrooms, and DMT, and under stimulants such as 6-APB, 4-FA, and 4-FMA. It also appears under dissociatives such as dextromethorphan and ephenidine, and under cannabinoids such as cannabis.

Novelty enhancement is felt as a brightening of attention: the ordinary world becomes absorbing, and things once passed over — a texture, a phrase, a familiar face — demand closer looking. Conceptual connections arise quickly, and ideas feel freighted with meaning they do not normally carry.

It often comes with a sense of delight or quiet wonder. Attending to an object or thought deepens the effect — noticing how interesting something is makes it more so. At higher doses, under psychedelics, the sense of discovery can border on revelation.

Novelty enhancement arises through different pathways depending on the drug class:

• Psychedelics — act on 5-HT2A receptors, disrupting habitual perceptual filtering; familiar stimuli reach awareness without the predictive shortcuts that normally suppress them.
• Stimulants — elevate dopamine in mesolimbic circuits, increasing stimulus salience and amplifying exploratory drive.
• Dissociatives — block NMDA receptors, fragmenting predictive processing so that expected and perceived input diverge.
• Cannabinoids — act on CB1 receptors, altering memory retrieval in ways that strip routine associations from familiar stimuli.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses raise both its likelihood and intensity. Set and setting matter considerably — novelty and open-minded engagement amplify the effect, especially under psychedelics and cannabinoids — as do disposition and prior history; people naturally inclined toward curiosity tend to find it stronger.

Expectation shapes it: going in with an intention to notice tends to be self-fulfilling. High tolerance and routine exposure to a substance tend to reduce it.